Matches in SemOpenAlex for { <https://semopenalex.org/work/W4282600306> ?p ?o ?g. }
- W4282600306 endingPage "2898" @default.
- W4282600306 startingPage "2898" @default.
- W4282600306 abstract "In lung cancer immunotherapy, biomarkers to guide clinical decisions are limited. We now explore whether the detailed immunophenotyping of circulating peripheral blood mononuclear cells (PBMCs) can predict the efficacy of anti-PD-1 immunotherapy in patients with advanced non-small-cell lung cancer (NSCLC). We determined 107 PBMCs subpopulations in a prospective cohort of NSCLC patients before starting single-agent anti-PD-1 immunotherapy (study group), analyzed by flow cytometry. As a control group, we studied patients with advanced malignancies before initiating non-immunotherapy treatment. The frequency of PBMCs was correlated with treatment outcome. Patients were categorized as having either high or low expression for each biomarker, defined as those above the 55th or below the 45th percentile of the overall marker expression within the cohort. In the study group, three subpopulations were associated with significant differences in outcome: high pretreatment levels of circulating CD4+CCR9+, CD4+CCR10+, or CD8+CXCR4+ T cells correlated with poorer overall survival (15.7 vs. 35.9 months, HR 0.16, p = 0.003; 22.0 vs. NR months, HR 0.10, p = 0.003, and 22.0 vs. NR months, HR 0.29, p = 0.02). These differences were specific to immunotherapy-treated patients. High baseline levels of circulating T cell subpopulations related to tissue lymphocyte recruitment are associated with poorer outcomes of immunotherapy-treated advanced NSCLC patients." @default.
- W4282600306 created "2022-06-14" @default.
- W4282600306 creator A5018670301 @default.
- W4282600306 creator A5027004121 @default.
- W4282600306 creator A5032503766 @default.
- W4282600306 creator A5039396525 @default.
- W4282600306 creator A5043337088 @default.
- W4282600306 creator A5045648722 @default.
- W4282600306 creator A5047280933 @default.
- W4282600306 creator A5062905201 @default.
- W4282600306 creator A5067529860 @default.
- W4282600306 creator A5070872244 @default.
- W4282600306 creator A5087052272 @default.
- W4282600306 creator A5088145681 @default.
- W4282600306 creator A5090680921 @default.
- W4282600306 date "2022-06-12" @default.
- W4282600306 modified "2023-10-15" @default.
- W4282600306 title "Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC" @default.
- W4282600306 cites W1838432821 @default.
- W4282600306 cites W1898345095 @default.
- W4282600306 cites W2000895546 @default.
- W4282600306 cites W2104347254 @default.
- W4282600306 cites W2119011446 @default.
- W4282600306 cites W2527905628 @default.
- W4282600306 cites W2528083170 @default.
- W4282600306 cites W2572174216 @default.
- W4282600306 cites W2617691667 @default.
- W4282600306 cites W2784283849 @default.
- W4282600306 cites W2796882786 @default.
- W4282600306 cites W2912725678 @default.
- W4282600306 cites W2916451481 @default.
- W4282600306 cites W3015473567 @default.
- W4282600306 cites W3016525073 @default.
- W4282600306 cites W3027648247 @default.
- W4282600306 cites W3098118704 @default.
- W4282600306 cites W3109276509 @default.
- W4282600306 doi "https://doi.org/10.3390/cancers14122898" @default.
- W4282600306 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35740564" @default.
- W4282600306 hasPublicationYear "2022" @default.
- W4282600306 type Work @default.
- W4282600306 citedByCount "4" @default.
- W4282600306 countsByYear W42826003062022 @default.
- W4282600306 countsByYear W42826003062023 @default.
- W4282600306 crossrefType "journal-article" @default.
- W4282600306 hasAuthorship W4282600306A5018670301 @default.
- W4282600306 hasAuthorship W4282600306A5027004121 @default.
- W4282600306 hasAuthorship W4282600306A5032503766 @default.
- W4282600306 hasAuthorship W4282600306A5039396525 @default.
- W4282600306 hasAuthorship W4282600306A5043337088 @default.
- W4282600306 hasAuthorship W4282600306A5045648722 @default.
- W4282600306 hasAuthorship W4282600306A5047280933 @default.
- W4282600306 hasAuthorship W4282600306A5062905201 @default.
- W4282600306 hasAuthorship W4282600306A5067529860 @default.
- W4282600306 hasAuthorship W4282600306A5070872244 @default.
- W4282600306 hasAuthorship W4282600306A5087052272 @default.
- W4282600306 hasAuthorship W4282600306A5088145681 @default.
- W4282600306 hasAuthorship W4282600306A5090680921 @default.
- W4282600306 hasBestOaLocation W42826003061 @default.
- W4282600306 hasConcept C121608353 @default.
- W4282600306 hasConcept C126322002 @default.
- W4282600306 hasConcept C137061746 @default.
- W4282600306 hasConcept C143998085 @default.
- W4282600306 hasConcept C167672396 @default.
- W4282600306 hasConcept C188816634 @default.
- W4282600306 hasConcept C196166836 @default.
- W4282600306 hasConcept C202751555 @default.
- W4282600306 hasConcept C203014093 @default.
- W4282600306 hasConcept C2776256026 @default.
- W4282600306 hasConcept C2777701055 @default.
- W4282600306 hasConcept C2781197716 @default.
- W4282600306 hasConcept C553184892 @default.
- W4282600306 hasConcept C55493867 @default.
- W4282600306 hasConcept C71924100 @default.
- W4282600306 hasConcept C86803240 @default.
- W4282600306 hasConcept C8891405 @default.
- W4282600306 hasConceptScore W4282600306C121608353 @default.
- W4282600306 hasConceptScore W4282600306C126322002 @default.
- W4282600306 hasConceptScore W4282600306C137061746 @default.
- W4282600306 hasConceptScore W4282600306C143998085 @default.
- W4282600306 hasConceptScore W4282600306C167672396 @default.
- W4282600306 hasConceptScore W4282600306C188816634 @default.
- W4282600306 hasConceptScore W4282600306C196166836 @default.
- W4282600306 hasConceptScore W4282600306C202751555 @default.
- W4282600306 hasConceptScore W4282600306C203014093 @default.
- W4282600306 hasConceptScore W4282600306C2776256026 @default.
- W4282600306 hasConceptScore W4282600306C2777701055 @default.
- W4282600306 hasConceptScore W4282600306C2781197716 @default.
- W4282600306 hasConceptScore W4282600306C553184892 @default.
- W4282600306 hasConceptScore W4282600306C55493867 @default.
- W4282600306 hasConceptScore W4282600306C71924100 @default.
- W4282600306 hasConceptScore W4282600306C86803240 @default.
- W4282600306 hasConceptScore W4282600306C8891405 @default.
- W4282600306 hasFunder F4320321411 @default.
- W4282600306 hasFunder F4320334923 @default.
- W4282600306 hasIssue "12" @default.
- W4282600306 hasLocation W42826003061 @default.
- W4282600306 hasLocation W42826003062 @default.
- W4282600306 hasLocation W42826003063 @default.